Quick Answer
Cardlytics, Inc. reported Net Income Loss of -$103.49 million for the year ending 2025.
- Cardlytics, Inc. showed an increase of +45.3% in Net Income Loss from 2024 to 2025.
- This data is from Cardlytics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: -$12.46 million | Q2 2017: -$648.0 thousand | Q3 2017: -$2.47 million | Q1 2018: -$20.06 million | Q2 2018: -$13.05 million | Q3 2018: -$8.37 million | Q1 2019: -$6.31 million | Q2 2019: -$6.51 million | Q3 2019: -$7.75 million | Q1 2020: -$13.53 million | Q2 2020: -$19.76 million | Q3 2020: -$15.36 million | Q1 2021: -$24.90 million | Q2 2021: -$47.31 million | Q3 2021: -$44.53 million | Q1 2022: $33.04 million | Q2 2022: -$126.29 million | Q3 2022: $6.27 million | Q1 2023: $13.61 million | Q2 2023: -$23.51 million | Q3 2023: -$23.97 million | Q1 2024: -$24.28 million | Q2 2024: -$4.26 million | Q3 2024: -$145.18 million | Q1 2025: -$13.28 million | Q2 2025: -$9.28 million | Q3 2025: -$72.67 million.
- Over the full 10 years of available data (2016 to 2025), Cardlytics, Inc.'s Net Income Loss has declined by 36.7%.
- Historical annual values: Fiscal year 2025: -$103.49 million | Fiscal year 2024: -$189.30 million | Fiscal year 2023: -$134.70 million | Fiscal year 2022: -$465.26 million | Fiscal year 2021: -$128.57 million | Fiscal year 2020: -$55.42 million | Fiscal year 2019: -$17.14 million | Fiscal year 2018: -$53.04 million | Fiscal year 2017: -$19.64 million | Fiscal year 2016: -$75.70 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: